Management of Paroxysmal Supraventricular Tachycardia (PSVT)
For acute PSVT management, begin immediately with vagal maneuvers (modified Valsalva maneuver preferred), followed by intravenous adenosine if unsuccessful, and proceed to synchronized cardioversion only if the patient is hemodynamically unstable or pharmacotherapy fails. 1
Acute Management Algorithm
Step 1: Assess Hemodynamic Stability
- Unstable patients (hypotension, altered mental status, chest pain with ischemia, acute heart failure): Proceed directly to synchronized cardioversion 1
- Stable patients: Follow stepwise approach below
Step 2: First-Line - Vagal Maneuvers (Stable Patients Only)
Modified Valsalva maneuver is superior to standard technique and should be attempted first 1, 2:
- Patient supine position
- Bear down against closed glottis for 10-30 seconds (generating 30-40 mmHg intrathoracic pressure)
- Success rate: ~43% with modified technique 3
Alternative vagal maneuvers if Valsalva fails 1:
- Carotid sinus massage (5-10 seconds after confirming no bruit) - less effective than Valsalva
- Ice-cold wet towel to face (diving reflex)
- Switching between techniques increases overall success to 27.7% 1
Critical pitfall: Never apply pressure to eyeballs - this is dangerous and abandoned 1
Step 3: Second-Line - Intravenous Adenosine
Adenosine terminates AVNRT in ~95% of patients and AVRT in 90-95% 1:
- Highly effective and recommended as first pharmacologic agent
- Brief side effects (<1 minute) occur in ~30% of patients
- Must have cardioversion equipment immediately available - adenosine can precipitate atrial fibrillation with rapid ventricular response, potentially leading to ventricular fibrillation 1
- Also serves diagnostic function by unmasking atrial activity in other arrhythmias 1
Step 4: Alternative IV Medications (If Adenosine Fails/Contraindicated)
For hemodynamically stable patients 1:
- IV diltiazem or verapamil: Particularly effective for AVNRT conversion (80-98% success rate)
- IV beta-blockers: Reasonable alternative with excellent safety profile, though less effective than calcium channel blockers
Critical contraindications for calcium channel blockers/beta-blockers 1:
- Never use in wide-complex tachycardia until VT excluded - can cause hemodynamic collapse or ventricular fibrillation
- Never use in pre-excited atrial fibrillation (WPW with AF) - can accelerate ventricular rate and cause ventricular fibrillation
- Avoid in systolic heart failure
- Avoid in severe conduction abnormalities
Step 5: Synchronized Cardioversion
Indications 1:
- Hemodynamically unstable patients (first-line after failed vagal maneuvers)
- Stable patients when pharmacotherapy fails or is contraindicated
- Highly effective for terminating all forms of SVT
Important caveat: Patients often have premature complexes post-cardioversion that may reinitiate tachycardia - antiarrhythmic drug may be needed to prevent recurrence 1
Long-Term Management
Definitive Treatment: Catheter Ablation
Catheter ablation is recommended as first-line therapy for preventing recurrent PSVT 3, 4:
- Single procedure success rates: 94.3-98.5% 3
- Safe and highly effective
- Curative in majority of patients
- Should be offered to all patients with symptomatic, recurrent PSVT
All patients treated for SVT should be referred to a heart rhythm specialist 5
Ongoing Pharmacologic Management
For patients who decline ablation or are not candidates 1:
First-line oral agents:
- Verapamil or diltiazem: Well-tolerated and effective alternatives to ablation 1
- Beta-blockers: Excellent safety profile
Key monitoring considerations:
- Watch for bradyarrhythmias and hypotension when initiating therapy
- Avoid calcium channel blockers in systolic heart failure
- Avoid beta-blockers in severe bronchospastic disease or significant conduction abnormalities 1
Evidence limitation: Long-term pharmacotherapy effectiveness data is limited compared to ablation 3, making catheter ablation the preferred definitive strategy for most patients with recurrent symptoms.
Special Considerations
Pre-excited atrial fibrillation (WPW syndrome) requires different management 1:
- Immediate cardioversion if unstable
- If stable: Use ibutilide or IV procainamide (NOT calcium channel blockers or beta-blockers)
- These agents slow accessory pathway conduction and may terminate AF
Oral "pill-in-the-pocket" strategy 1:
- Oral beta-blockers, diltiazem, or verapamil may be reasonable for acute self-treatment
- Limited evidence for effectiveness
- Delayed onset of action compared to IV formulations
- Can be used in conjunction with vagal maneuvers, particularly when IV access unavailable